PADI4 and interstitial lung disease: Unfortunately, a potential association between anti-PAD4 IgA and mucosal inflammation or with other potentially associated relevant clinical features such as pulmonary manifestations, including ILD, could not be assessed in our study due to the lack of clinical information in this direction.